TP5: Deactivation of autoimmune disease-promoting functions of neutrophil granulocytes by apoptotic cells
Activated neutrophis are responsible for the tissue damage observed in several autoimmune diseases. Recent studies of the research group revealed that neutrophils can recognize and phagocytose apoptotic cells (Esmann et al, J. Immunol, 184:391, 2010). More importantly, phagocytosis of apoptotic cells results in the inhibition of proinflammatory neutrophil functions such as oxidative burst or secretion of inflammatory mediators. Goal of the project is to investigate whether this deactivating effect can be used to suppress neutrophil-mediated tissue damage in autoimmune diseases. Human neutrophils will be activated with immune complexes and/or ANCA and a variety of neutrophils functions will be assayed in vitro in the presence or absence of apoptotic cells. Analysis of activating signalling steps will be carried out to clarify the molecular mechanisms responsible for the observed effects. The air-pouch technique will be used to assess the effect of apoptotic cells on activated neutrophils in vivo.
Sara Roth graduated in 09/2015 and is now working as a PostDoc in Australia.
- Projects
- Projects
- Associated projects
- MD projects
- Associated MD projects
- Concluded projects
- Concluded TP
- TP1 - Modulation of isotypes
- TP2 - Targeted fusion proteins
- TP3 - Selective FcRn inhibition
- TP4 - IL-35, Treg and EAE
- TP5 - Apoptotic cells
- TP6 - Mast cell / T cell interactions
- TP7 - Fc gamma receptors
- TP8 - IgG- and C-receptors
- TP9 - IVIG
- TP10 - HMGB1 Protein
- TP11 - IL15 / IL15Rα
- TP12 - S100 proteins
- TP13 - Treatment-refractory B cells
- TP A1 - Treatment strategies
- TP A2 - B cell inhibition
- TP A3 - IL-17 in EBA
- TP A4 - The pathophysiological role of Th17cells in Bullous pemphigoid
- TP A5 - C5a/C5aR
- TP A6 - Signals leading to glycosylated antibodies
- TP A7 - IL-16 & MIF in autoimmunity
- TP B1 - B cell transcriptome
- TP B2 - Antigen-specific T cells
- TP B3 - Metabolomics
- TP B4 - Resident plasma cells
- TP B5 - Anti-CD37 antibodies
- TP B6 - Systemic Sclerosis
- Concluded Ass.TP
- Concluded MD TP
- Concluded Ass. MD TP
- Concluded TP